01st January 2021

New international research examines way of fighting back against Covid-19

Researchers at Swansea University Medical School are helping to drive forward understanding of the virus that causes Covid-19 and how it can be tackled. The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the etiological agent of Covid-19, has swept across the world with unprecedented speed. Since it was initially identified there have been more than…

01st January 2021

Medical School course records triple exam success

Swansea University’s physician associate course is celebrating a remarkable hat trick – its students recorded a 100 per cent pass rate in the September PA National Exams for the third year running. The MSc Physician Associate Studies course was only launched in 2016 but it has already achieved great success and been rewarded by receiving…

01st January 2021

Development Bank of Wales and Creo Medical Co-Invest

The Development Bank of Wales is co-investing with corporate investor Creo Medical Group plc alongside other funders as part of a £1.5 million equity round into IQ Endoscopes Ltd. The investment will support the rapid product development of the IQ platform – a range of single use flexible endoscopes which provides images of the full…

01st January 2021

Older, Poorer People At Greater Risk OF Adverse Drug Reactions

A review by Swansea University academics has found that older, poorer people who are socially distanced from their doctors or pharmacists, suffer more adverse drug reactions (ADRs) than the general population and that systematic monitoring is needed to protect these patients suffering from reactions which could result in over-sedation, falls, or drug-induced Parkinsonism. The paper,…

01st January 2021

Researchers to develop test for children most at risk of severe short-sightedness

Researchers funded by Fight for Sight in partnership with Welsh Government, through Health and Care Research Wales, are developing a genetic test to identify people with severe short-sightedness (high myopia) who are most at risk of permanent damage to their eyesight and thus benefit from more frequent monitoring. The test may also help to identify…

01st January 2021

Wales’ first plasmapheresis donor backs call for more donors in Wales to step forward

The first donor in Wales to donate plasma through the Welsh Blood Service’s new ‘plasmapheresis’ process is calling on other males who have recovered from COVID-19 to consider donating their plasma to support medical trials. Clinical trials are currently underway to explore if the antibody-rich plasma of recovered COVID-19 patients could be used in the…

01st January 2021

EKF Among New Occupiers At LLandough Trading Estate

A spate of lettings has led to three of four recently-refurbished industrial units at the Llandough Trading Estate in Cardiff becoming occupied. EKF is one of the new occupiers. The four industrial, distribution and trade counter units have been refurbished, including new roofing, decoration and the complete refurbishment of office accommodation. Unit 20 has been…

30th December 2020

Covid: Oxford-AstraZeneca vaccine rollout to start in Wales next week

The rollout of a second Covid-19 vaccine across Wales will begin next week, the Welsh Government has said. The coronavirus vaccine designed by scientists at the University of Oxford was approved for use in the UK on Wednesday. The UK has ordered 100 million doses from the manufacturer AstraZeneca – enough to vaccinate 50 million…

16th December 2020

Cardiff elects Innovation Fellows

Cardiff University has appointed three Innovation Fellows in recognition of their outstanding work to grow lasting University partnerships.
15th December 2020

EKF introduces accurate quantitative COVID-19 antibody test kit

EKF Diagnostics, the global in vitro diagnostics company, has introduced one of the first tests to precisely measure levels of COVID-19 neutralising antibodies in individuals. Unlike other antibody tests, the Kantaro COVID-SeroKlir SARS-CoV-2 IgG ant